Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 February 2006 to 28 February 2006 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC) 
Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 February 2006 to 28 February 2006 
(Decisions taken pursuant to Article 34 of Directive 2001/83/EC [1] or Article 38 of Directive 2001/82/EC [2]) 
(2006/C 78/04) 
— Issuing, maintenance or modification of a national marketing authorisation 
Date of the decision | Name(s) of the medicinal product | Holder(s) of the marketing authorization | Member State concerned | Date of notification | 
21.2.2006 | Lanzoprazol ratiopharm | See Annex I | See Annex I | 23.2.2006 | 
21.2.2006 | Lansoprazol ABZ-Pharma | See Annex II | See Annex II | 23.2.2006 | 
21.2.2006 | Lansoprazol CT-Arzneimittel | See Annex III | See Annex III | 23.2.2006 | 
[1] OJ L 311, 28.11.2001, p. 67. 
[2] OJ L 311, 28.11.2001, p. 1. 
-------------------------------------------------- 
ANNEX I 
LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, APPLICANT, MARKETING AUTHORISATION HOLDER IN THE MEMBER STATES 
Member State | Marketing Authorisation Holder | Applicant | Invented name | Strength | Pharmaceutical Form | Route of administration | 
Austria | — | ratiopharm Arzneimittel Vertriebs-GmbH Albert-Schweitzer-G. 3 A-1140 Wien | Lansoprazol %quot%ratiopharm%quot% 15 mg Kapseln | 15 mg | Gastro-resistant capsule, hard | Oral use | 
Lansoprazol %quot%ratiopharm%quot% 30 mg Kapseln | 30 mg | Gastro-resistant capsule, hard | Oral use | 
Belgium | — | ratiopharm Belgium Rue Saint-Lambert 14 B-1120 Bruxelles/Brussel | Lansoprazol-ratiopharm 15 mg gelules gastro-résistante | 15 mg | Gastro-resistant capsule, hard | Oral use | 
Lansoprazol-ratiopharm 30 mg gelules gastro-résistante | 30 mg | Gastro-resistant capsule, hard | Oral use | 
Denmark | — | ratiopharm GmbH Graf-Arco-Straße 3 D-89079 Ulm | Lantrolix 15 mg enterokapsler, hårde | 15 mg | Gastro-resistant capsule, hard | Oral use | 
Lantrolix 30 mg enterokapsler, hårde | 30 mg | Gastro-resistant capsule, hard | Oral use | 
Finland | ratiopharm GmbH Graf-Arco-Straße 3 D-89079 Ulm | — | Lansoprazol ratiopharm 15 mg | 15 mg | Gastro-resistant capsule, hard | Oral use | 
Lansoprazol ratiopharm 30 mg | 30 mg | Gastro-resistant capsule, hard | Oral use | 
Germany | — | ratiopharm GmbH Graf-Arco-Straße 3 D-89079 Ulm | Lansoprazol-ratiopharm 15 mg Hartkapseln | 15 mg | Gastro-resistant capsule, hard | Oral use | 
Lansoprazol-ratiopharm 30 mg Hartkapseln | 30 mg | Gastro-resistant capsule, hard | Oral use | 
Italy | — | ratiopharm GmbH Graf-Arco-Straße 3 D-89079 Ulm | Lansoprazolo ratiopharm 15 mg capsule di gelatina dura | 15 mg | Gastro-resistant capsule, hard | Oral use | 
Lansoprazolo ratiopharm 30 mg capsule di gelatina dura | 30 mg | Gastro-resistant capsule, hard | Oral use | 
Luxembourg | — | ratiopharm GmbH Graf-Arco-Straße 3 D-89079 Ulm | Lansoprazol-ratiopharm 15 mg Hartkapseln | 15 mg | Gastro-resistant capsule, hard | Oral use | 
Lansoprazol-ratiopharm 30 mg Hartkapseln | 30 mg | Gastro-resistant capsule, hard | Oral use | 
Portugal | — | ratiopharm Lda, Portugal Edifício Tejo, 6.o piso Rua Quinta do Pinheiro P-2790-143 Carnaxide | Lansoprazol ratiopharm 15 mg cápsulas gastro-resistentes | 15 mg | Gastro-resistant capsule, hard | Oral use | 
Lansoprazol ratiopharm 30 mg cápsulas gastro-resistentes | 30 mg | Gastro-resistant capsule, hard | Oral use | 
Sweden | — | ratiopharm GmbH Graf-Arco-Straße 3 D-89079 Ulm | Sopranix 15 mg, enterokapsler, hårda | 15 mg | Gastro-resistant capsule, hard | Oral use | 
Sopranix 30 mg, enterokapsler, hårda | 30 mg | Gastro-resistant capsule, hard | Oral use | 
-------------------------------------------------- 
ANNEX II 
LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, APPLICANT, MARKETING AUTHORISATION HOLDER IN THE MEMBER STATES 
Member State | Marketing Authorisation Holder | Applicant | Invented name | Strength | Pharmaceutical Form | Route of administration | 
Finland | ratiopharm GmbH Graf-Arco-Str. 3 D-89075 Ulm | — | Lansoprazol AbZ-Pharma 15 mg | 15 mg | Gastro-resistant capsule, hard | Oral use | 
Lansoprazol AbZ-Pharma 30 mg | 30 mg | Gastro-resistant capsule, hard | Oral use | 
Germany | — | ratiopharm GmbH Graf-Arco-Str. 3 D-89075 Ulm | Lansoprazol AbZ 15 mg Hartkapseln | 15 mg | Gastro-resistant capsule, hard | Oral use | 
Lansoprazol AbZ 30 mg Hartkapseln | 30 mg | Gastro-resistant capsule, hard | Oral use | 
-------------------------------------------------- 
ANNEX III 
LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, APPLICANT, MARKETING AUTHORISATION HOLDER IN THE MEMBER STATES 
Member State | Marketing Authorisation Holder | Applicant | Invented name | Strength | Pharmaceutical Form | Route of administration | 
Finland | ratiopharm GmbH Graf-Arco-Straße 3 D-89079 Ulm | — | Lansoprazol CT-Arzneimittel 15 mg | 15 mg | Gastro-resistant capsule, hard | Oral use | 
Lansoprazol CT-Arzneimittel 30 mg | 30 mg | Gastro-resistant capsule, hard | Oral use | 
Germany | — | ratiopharm GmbH Graf-Arco-Straße 3 D-89079 Ulm | Lansoprazol-CT 15 mg Hartkapseln | 15 mg | Gastro-resistant capsule, hard | Oral use | 
Lansoprazol-CT 30 mg Hartkapseln | 30 mg | Gastro-resistant capsule, hard | Oral use | 
-------------------------------------------------- 
